Be the first to like this
Rare cancers are those affecting very small numbers and up to now have been poorly diagnosed, researched, funded, and treated, resulting in very high death rates even as morbidity for common cancers decline.
Diagnostic breakthroughs like genome sequencing make earlier stage diagnosis possible and breakthroughs in personalized treatment, including cell and gene therapies, provide new hope, including potential cures.
CCSN welcomed our host panelist Durhane Wong-Rieger, President & CEO of Canadian Organization for Rare Disorders and Chair of Rare Disease International. Durhane was joined by Lisa Machado, Founder and Chair of the CML Network for this engaging and educational webinar on the unique issues presented in rare cancers.
The webinar was followed by a question & answer session.